Real-world experience with ocrelizumab in primary Progressive multiple sclerosis: Insights from the MSOCR-P cohort, a MSBase Registry sub-study

Butzkueven H., Spelman T., ÖZAKBAŞ S., Laureys G., Van Hijfte L., Alroughani R., ...More

38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Netherlands, 26 - 28 October 2022, vol.28, pp.384-386 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 28
  • City: Amsterdam
  • Country: Netherlands
  • Page Numbers: pp.384-386
  • Karadeniz Technical University Affiliated: Yes